February 02, 2019
Weil advised athenahealth, Inc., a provider of network-based medical record, revenue cycle, patient engagement, care coordination and population health services for medical groups and health systems, in its $5.7 billion sale to Veritas Capital and Evergreen Coast Capital (an affiliate of Elliott Management Corporation), combined with Virence Health (a portfolio company of Veritas Capital), a provider of revenue and workflow management services for hospitals and physician practices. The combined business operates under the athenahealth brand. The transaction closed on February 2, 2019.
The Weil team that advised athenahealth was led by Mergers & Acquisitions partner Michael Aiello and included Mergers & Acquisitions partner Sachin Kohli and Mergers & Acquisitions associates Katie Simmonds, Stephen Liebscher, Sam Hulsey and Daniel Sotsky (Not Yet Admitted in New York); Banking & Finance partner Gabriel Gregson; Capital Markets partner Heather Emmel; Technology & IP Transactions Head Michael Epstein; Tax partner Chayim Neubort; Executive Compensation & Benefits Head Paul Wessel; Cybersecurity, Data Privacy & Information Management Co-Head Randi Singer; Real Estate partner David Herman; Environmental Head Annemargaret Connolly; Antitrust/Competition Co-Head Steven Newborn and partner Brianne Kucerik; White Collar Defense, Regulatory and Investigations Co-Head Steven Tyrrell; Environmental counsel John O’Loughlin; Capital Markets associate Aman Singh; Tax associate Adam Arikat; Executive Compensation & Benefits associates Amanda Rosenblum and Tamara Roth; Technology & IP Transactions associates Lauren Springer and Alexa Rozell; Real Estate associates Melissa Meyrowitz and Elizabeth Jaikaran; Antitrust/Competition associates Kristin Sanford and Jonathan Goldsmith; Complex Commercial Litigation associate Eliza Cotter; and Regulatory associate Timothy Welch.